Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Cardiokine
company
About
Cardiokine, Inc., a specialty pharmaceutical company, engages in the development of pharmaceuticals for the prevention and treatment of
- 11 - 50
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $37M
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2003
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Cardiokine, Inc., a specialty pharmaceutical company, engages in the development of pharmaceuticals for the prevention and treatment of cardiovascular diseases. Its products include lixivaptan, an orally active vasopressin receptor antagonist for patients with congestive heart failure who suffer from hyponatremia. The company was founded in 2004 and is headquartered in Philadelphia, Pennsylvania.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$87M
Cardiokine has raised a total of
$87M
in funding over 2 rounds. Their latest funding was raised on
May 1, 2006 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 1, 2006 | Series B | $50M | 1 | — | — | Detail |
| Apr 13, 2004 | Series A | $37M | 1 |
Perseus-Soros Biopharmaceutical Fund
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Cardiokine is funded by 1 investors.
Perseus-Soros Biopharmaceutical Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Perseus-Soros Biopharmaceutical Fund
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
